| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 17,650 | $30 | $582.5K |
| J9312 | Injection, rituximab, 10 mg | 5,560 | $60 | $350.3K |
| J3262 | Injection, tocilizumab, 1 mg | 75,640 | $1 | $302.6K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 2,240 | $80 | $188K |
| J0897 | Injection, denosumab, 1 mg | 10,320 | $20 | $185.8K |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 6,980 | $30 | $181.5K |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | 15,150 | $10 | $151.5K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 710 | $100 | $68.1K |
| 96401 | The provider administers nonhormonal, antineoplastic chemotherapy drugs subcutaneously or intramuscularly to the patient. | 260 | $50 | $13.9K |
| 20611 | In this procedure, the provider inserts a needle through the skin of a patient and into a major joint or bursa, typically the shoulder, hip, knee, or subacromial bursa, and then uses the syringe… | 150 | $70 | $10.1K |